Sponsored Link:

Page Analysis

Sponsored Link:


484 ratings.806 user reviews.

Web page information

  1. Keywords hit in search results
    above activated address against agents allows analysis anticancer average basic before below breaking breast buyins camera cancer cantor change chart charts closed comments companies company compare competitors create detailed development earnings email favorite finance fitzgerald focused historical history imagine immunogen information investing investment latest licenses login lower manufacturing merge molecule moving nasdaq norwood optimise ordinary other password photos places potency power price prices prodrug profile questions quote quotes range reach remember scenes share shares small smartermail start stats stock stocks summary taken target technical technology their thestreet three today toxicity trading tumor unfavorable uptrend user@example volume webmaster welcome yahoo zacks
  2. Search Engine Recommended Keywords
    InvestorVillage IMGN, IMGN Message Boards, IMGN Yahoo! Finance, IMGN Stock-Rating, IMGN Google, IMGN News, ImmunoGen, Vrtx,
Add your photos and merge them into 3D scenes! imgn.it allows you to create 3D scenes from photos taken with an ordinary camera. Show Your favorite places, look at ...
Imagine-it - Imagine, the power of many...
Welcome: If you wish to reach the webmaster for any questions or comments, you can do so below
IMGN: Summary for ImmunoGen, Inc.- Yahoo! Finance
View the basic IMGN stock chart on Yahoo! Finance. Change the date range, chart type and compare ImmunoGen, Inc. against other companies.
SmarterMail Login - SmarterMail - Imagine-it - Imagine, the power ...
Email Address (ex. user@example.com) Password Remember me
ImmunoGen, Inc.
Licenses tumor-activated prodrug technology, for development of small molecule anticancer agents, to optimise potency and toxicity. Manufacturing in Norwood, and ...
Three Stocks to See Before You Start the Trading Week: PIP, IMGN ...
Focused Small Caps: Three Stocks to See Before You Start the Trading Week: PIP, IMGN, PRKR
IMGN: Stock Quote - Immunogen Inc. Stock Price Today - TheStreet
Immunogen Inc. stock price today: (IMGN) stock quote, price history, earnings per share, technical analysis chart and breaking news.
IMGN: Immunogen Inc Stock Quote & Analysis - Zacks.com
View Immunogen Inc IMGN investment & stock information. Get the latest Immunogen Inc IMGN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.
IMMUNOGEN INC (IMGN:NASDAQ GS): Stock Quote & Company Profile ...
IMMUNOGEN INC (IMGN:US) stock price & investing information. Find IMMUNOGEN INC historical stock quotes, key competitors, stock data, executives and company news.
IMGN - Stock Quote for ImmunoGen Inc - MSN Money
US:IMGN - Get Stock quote detail for ImmunoGen Inc. Stock quotes include the latest US:IMGN market price and fundamental investing data, price charts and

News Results

BUYINS.NET: FELE, IMGN, HDNG, KRO, IT, AVD Expected To Be Up Before Next Earnings Releases
Jun 19, 2012 (M2 PRESSWIRE via COMTEX) -- BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released in the coming weeks and determining how the stocks have performed Before their last 12 ...
ImmunoGen (IMGN) Showing Bullish Technicals With Support At $14.64
Friday, June 22, 2012... ImmunoGen (NASDAQ:IMGN) closed Thursday's unfavorable trading session at $14.95. In the past year, the stock has hit a 52-week low of $9.17 and..... Tuesday, June 12, 2012... ImmunoGen (NASDAQ:IMGN) closed Monday's unfavorable ...
Market Intelligence Center
Shares of IMGN Up 13.1% Since Uptrend Call on Shares
SmarTrend identified an Uptrend for Immunogen (NASDAQ:IMGN) on May 14th, 2012 at $13.71. In approximately 1 month, Immunogen has returned 13.06% as of today's recent price of $15.50. Over the past year, Immunogen has traded in a range of $9.17 to $16.20 ...
Comtex Smartrend
Buyers Accumulate Shares of Immunogen, Up 2.3%
Immunogen (NASDAQ:IMGN), a company whose shares are moving quickly, is trading 2.3% higher to $15.39. The S&P is currently trading fractionally lower to 1,340 and the Dow Jones Industrial Average is trading 0.3% lower to 12,730. ImmunoGen, Inc. develops ...
Financial News Network Online
Cantor Fitzgerald Starts Immunogen Inc. (IMGN) at Hold, $15 Target
Cantor Fitzgerald initiated coverage on Immunogen Inc. (NASDAQ: IMGN) with a Hold rating and a $15 price target Wednesday afternoon. The firm said the company "is approaching commercial revenue via a partnership with Roche, and this is a solid positive for ...
Immunogen's Shares Changing Hands at Lower Prices on 1.2x Above-Average Volume (IMGN)
Shares of Immunogen are trading down 5.0% to $14.20 today on above average volume. Today's volume of 616,000 shares tops the average 30-day volume of 506,000 shares. Spikes in volume can validate a breakout or signify a potential turning point. ImmunoGen ...
Financial News Network Online
Immunogen Crosses Below its 10-day MA (IMGN)
Immunogen (NASDAQ:IMGN) shares have crossed bearishly below their 10-day moving average of $14.45 on a volume of 662K shares. This may provide swing traders with an opportunity for a short position, as such a crossover often suggests lower prices in the ...
Comtex Smartrend
Protesters push FDA on breast cancer drug at BIO conference
based Immunogen Inc. (Nasdaq: IMGN). The drug candidate is indicated for patients with HER2+ breast cancer, which is one of the deadliest forms. “I have been taking this drug for 19 months, with no side effects, and I have no cancer,” one of ...
The Business Journal
No Coupons found for this website.

500 characters left

Your Review: (5 out of 5)
refresh captcha

Server Information
IP Address:
Powered By:ASP.NET
ASP.net version:4.0.30319
Site Disclaimer:

All trademarks are the property of their respective owners. The facts, figures, reviews, records, stats, and other data presented on this page is for suggestion and information purposes only. PageGlimpse.com is not responsible for any incorrect or incomplete information. PageGlimpse.com does not take responsibility for any user-reviews of websites inside its resource and reserves the right to keep or remove those. It is highly recommended that you review all the data for accuracy.